State Of Wisconsin Investment Board Gritstone Bio, Inc. Transaction History

State Of Wisconsin Investment Board

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.77 - $4.34 $291,165 - $713,930	-164,500 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.03 - $12.19 $328,848 - $994,704	81,600 Added 98.43%	164,500 $678,000
Q4 2021 Feb 11, 2022	BUY	$8.76 - $13.71 $484,428 - $758,163	55,300 Added 200.36%	82,900 $1.07 Million
Q3 2021 Nov 12, 2021	SELL	$6.41 - $13.54 $13,461 - $28,434	-2,100 Reduced 7.07%	27,600 $298,000
Q1 2021 May 17, 2021	BUY	$4.07 - $27.11 $120,879 - $805,167	29,700 New	29,700 $280,000

Q4 2020 Feb 03, 2021	SELL	$2.57 - $4.22 $123,359 - $202,560	-48,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$2.63 - $8.09 $7,890 - $24,270	-3,000 Reduced 5.88%	48,000 $127,000
Q2 2020 Aug 12, 2020	BUY	$5.69 - $8.17 $71,125 - $102,125	12,500 Added 32.47%	51,000 $339,000
Q1 2020 May 06, 2020	BUY	$5.47 - $11.3 $6,017 - $12,430	1,100 Added 2.94%	38,500 $224,000
Q3 2019 Nov 12, 2019	BUY	$8.45 - $12.28 $231,529 - $336,472	27,400 Added 274.0%	37,400 $323,000
Q2 2019 Aug 14, 2019	BUY	$9.2 - $15.7 $92,000 - $157,000	10,000 New	10,000 $111,000

45.6M

861K

4.52M

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $45.3M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.